Clinical trial

Effect of Dapagliflozin on IAH in T1DM

NCT03556033

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Dapagliflozin Normalized identity: dapagliflozinView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo oral capsule Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Effect of Dapagliflozin on IAH in T1DM

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2018-11-23

PhasePHASE2

Conditions

Diabetes Mellitus, Type 1candidate · MONDO: type 1 diabetes mellitus

Hypoglycemiaverified · MONDO: hypoglycemia

Hypoglycemia Unawarenessunresolved

Interventions

DapagliflozinDRUG · verified · RxNorm: dapagliflozin

Placebo oral capsuleDRUG

Sponsors & collaborators

Radboud University Medical Centerlead sponsor

Mapped research locations

NijmegenNetherlands1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03556033 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.